Serotypes and Antimicrobial Susceptibility of Group B Streptococcus Isolated from Neonates in Casablanca
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 32 (3) , 339-340
- https://doi.org/10.1080/00365540050166108
Abstract
The serotypes and the levels of antibiotic resistance of 59 Streptococcus agalactiae isolates from neonates in Casablanca, from February 1992 to July 1997, were studied. Most of the isolates (86.4%) were recovered from early-onset disease. The serotype distribution was as follows: serotype III 39%; serotype Ia 32.2%; and serotype V 10.2%. All strains were susceptible to penicillin G, cefotaxime and ampicillin, whereas 1 strain was resistant to erythromycin. No high level of resistance to gentamicin was detected. A vaccine should comprise the most prevalent serotypes and also provide protection against serotype V disease. The antibiotic susceptibility patterns reported here support the recommended treatment and prophylaxis of invasive group B Streptococcal disease.Keywords
This publication has 4 references indexed in Scilit:
- Infection néonatale à streptocoque du groupe B à Casablanca (Maroc)Medecine Et Maladies Infectieuses, 1998
- Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Invasive Group B Streptococcal Disease: The Emergence of Serotype VThe Journal of Infectious Diseases, 1996
- Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococciAntimicrobial Agents and Chemotherapy, 1994